Timing note: The event date provided is Thursday, August 6, 2026. As of that date, AFL’s 2Q26 earnings call is today, rather than tomorrow. This preview is framed around the key issues investors should focus on for the report/call.
Aflac enters 2Q26 with a constructive operating setup: strong Japan sales momentum, steady U.S. premium growth, substantial excess capital, and ongoing share repurchases. The central question is whether these positives are translating into durable underlying earnings growth—or are being offset by pressure from Japan in-force premiums, U.S. expense investment, variable investment income, and a newly disclosed cyber incident at Aflac Japan.
The stock closed at $125.59 on August 5, up roughly 13.9% year to date, suggesting the market has already credited AFL for improved operating momentum and capital return. The call therefore matters at least as much as the headline adjusted EPS result: investors will be looking for confidence that favorable claims experience, sales gains, and capital flexibility can persist.
Japan remains the principal driver of AFL’s earnings power, and it is also the area where the distinction between sales growth and in-force premium growth is most important.
In 1Q26, Aflac Japan posted:
The new medical product Anshin Palette, cancer product Miraito, and first-sector offering Tsumitasu are driving sales. Management’s stated ambition is approximately ¥80 billion of Japan sales for 2026, versus roughly ¥74 billion in 2025. That is meaningful progress, but management has also indicated that approximately ¥90 billion of annual sales would be needed to get Japan earned premiums to roughly flat.
What investors should watch:
Interpretation: Strong sales are strategically important, but an earnings-positive rerating likely requires clearer evidence that sales can eventually stabilize—or reverse—the decline in the Japan in-force premium base.
Aflac Japan’s 1Q26 benefit ratio was 62.9%, down 290 basis points year over year. That result was aided by favorable experience and reserve remeasurement gains; management estimated that gains exceeding its plan benefited the ratio by roughly 70 basis points.
The company reaffirmed a 60%–63% full-year Japan benefit-ratio outlook in the first-quarter call. That range remains a key earnings swing factor.
Key questions for the call:
A result near the favorable end of the range would support upside to operating earnings. Conversely, an adverse claims normalization could quickly offset sales and investment-income strength.
Aflac U.S. began 2026 with stable fundamentals:
| 1Q26 Aflac U.S. metric | Result |
|---|---|
| Net earned premium growth | +3.5% |
| Sales growth | +2.9% |
| Persistency | 79.3% |
| Pretax adjusted earnings | $363M |
| Pretax adjusted margin | 20.4% |
| Benefit ratio | 47.2% |
| Expense ratio | 38.3% |
The more encouraging underlying point is product mix. Management cited 12.4% growth across group products, including dental and vision, core voluntary benefits, and group life/disability. Dental and vision sales were up 52%. However, the traditional agent-based business was described as slightly down to flat.
That makes 2Q a test of whether AFL can sustain growth in newer distribution channels while improving the productivity and recruitment economics of its core agency channel.
What to watch:
Interpretation: U.S. revenue growth is becoming more credible, but profitability depends on management’s ability to prevent growth investments and product-mix change from eroding the roughly 20% pretax margin.
AFL’s headline GAAP earnings can move sharply with derivatives, foreign exchange, and investment marks. The cleaner measure for the quarter will again be adjusted EPS, segment pretax earnings, and normalized investment income.
In 1Q26:
The 2Q25 comparison also contains noise: adjusted EPS was $1.78, but variable investment income was $35 million below long-term expectations and a Japan make-whole call added $35 million of investment income.
Investor focus:
On June 30, 2026, Aflac disclosed that Aflac Japan identified unauthorized access to certain systems between June 15 and June 25, 2026. The company suspended certain systems, stated that it continued serving policyholders, and said affected files included policy/coverage details, personal information, and bank-account information. The U.S. business systems were not accessed. The investigation remains ongoing, and AFL said the ultimate impact was not yet known.
This disclosure falls directly within the second quarter and is likely to be a central call topic.
Questions investors should expect to be answered:
The stock fell roughly 2.4% on June 30 following the disclosure, but recovered and closed about 7.1% above that level by August 5. That recovery suggests investors may currently view the episode as manageable; a vague or materially worse-than-expected update would therefore be a notable downside risk.
AFL’s capital position remains a material strength:
Capital return supported first-quarter per-share earnings growth even as consolidated adjusted earnings were nearly flat year over year. Investors should look for the pace of 2Q buybacks and management’s willingness to continue deploying excess capital, especially after issuing debt in May.
The strategic wrinkle is Japan reinsurance. AFL completed a small external Japan reinsurance transaction in 1Q and views the market as a potentially meaningful long-term use of capital. That could diversify earnings and create attractive returns, but it also raises the question of whether future capital deployment tilts modestly from buybacks toward growth investments.
| Metric | 2Q25 actual | 1Q26 actual | 2Q26 investor focus |
|---|---|---|---|
| Adjusted EPS | $1.78 | $1.75 | EPS growth excluding FX and one-offs |
| Adjusted earnings | $957M | $901M | Underlying earnings momentum |
| Japan pretax adjusted earnings | $790M | $759M | Sales, benefit ratio, yen earnings |
| Japan pretax margin | 32.0% | 35.0% | Sustainability of claims favorability |
| Japan sales | ¥20.7B | ¥17.7B | Progress toward ~¥80B 2026 aspiration |
| U.S. pretax adjusted earnings | $388M | $363M | Margin resilience amid investment spend |
| U.S. net earned-premium growth | +3.4% | +3.5% | Durability of group-led growth |
| U.S. sales growth | +2.7% | +2.9% | Group momentum versus core-agent softness |
Note: 2Q25 adjusted EPS included an unfavorable $0.05 per-share variable-investment-income shortfall and a $0.05 per-share benefit from a Japan make-whole call, complicating the year-over-year comparison.
The most investable issue is not simply whether AFL beats the quarter’s adjusted EPS expectation. It is whether management can demonstrate that Japan’s new-product sales momentum is durable, U.S. group expansion can offset weakness in the traditional agency channel, and cyber-related disruption is contained.
A strong quarter would pair healthy Japan sales and benefit-ratio discipline with stable U.S. margins, manageable credit marks, a clear cyber update, and continued aggressive capital return. The most consequential negative surprise would be evidence that the cyberattack or Japan premium dynamics impair the medium-term earnings trajectory.